Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
Cancers|January 21, 2022
High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma PatientsDario Marino, Marco Pizzi, Iuliia Kotova, et al.
Frontiers in Oncology|November 4, 2022
A bone-based 3D scaffold as an in-vitro model of microenvironment-DLBCL lymphoma cell interactionJessica Ceccato, Maria Piazza, Marco Pizzi, et al.
Oncotarget|October 31, 2015
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survivalValentina Trimarco, Elisa Ave, Monica Facco, et al.
Oncotarget|September 9, 2017
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory propertiesFederica Costa, Rosanna Vescovini, Marina Bolzoni, et al.
Cancers|December 10, 2021
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell LymphomaGiulia Bega, Jacopo Olivieri, Marcello Riva, et al.
Annals of Hematology|April 30, 2024
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experienceNicolò Danesin, Laura Bonaldi, Annalisa Martines, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life EvaluationRenato Zambello, Laura Bonaldi, Tamara Berno, et al.
Frontiers in Oncology|November 1, 2021
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell LymphomaSabrina Manni, Anna Fregnani, Laura Quotti Tubi, et al.
Cancers|September 9, 2022
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple MyelomaAnna Fregnani, Lara Saggin, Ketty Gianesin, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 3, 2015
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic LeukemiaAndrea Visentin, Monica Facco, Federica Frezzato, et al.
Pageof 26